Application Information

This drug has been submitted to the FDA under the reference 021943/001.

Names and composition

"LAMIVUDINE; ZIDOVUDINE" is the commercial name of a drug composed of LAMIVUDINE and ZIDOVUDINE and EFAVIRENZ.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021943/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ TABLET/ ORAL 150MG and 300MG and 600MG
022296/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 30MG and 60MG
077411/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 150MG and 300MG
078929/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 150MG and 300MG
079079/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 150MG and 300MG
090679/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 150MG and 300MG
200748/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 30MG and 60MG
201151/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL 30MG and 60MG
202814/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET, FOR SUSPENSION/ ORAL 30MG and 60MG
204914/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE TABLET/ ORAL SUSPENSION 30MG and 60MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021943/001 LAMIVUDINE; ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ TABLET/ ORAL 150MG and 300MG and 600MG
022096/001 LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ TABLET/ ORAL 150MG and 300MG and 600MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved